Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Pulmonary hypertension in chronic lung disease and hypoxia.

Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801914. doi: 10.1183/13993003.01914-2018. Print 2019 Jan.

2.

Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.

Lang IM, Gaine SP.

Eur Respir Rev. 2015 Dec;24(138):630-41. doi: 10.1183/16000617.0067-2015. Review. Erratum in: Eur Respir Rev. 2016 Mar;25(139):99. Eur Respir Rev. 2017 Jan 3;26(143):.

3.

[Treatment goals of pulmonary hypertension].

McLaughlin VV, Gaine SP, Howard LS, Leuchte HH, Mathier MA, Mehta S, Palazzini M, Park MH, Tapson VF, Sitbon O.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:95-105. Turkish.

4.

Treatment goals of pulmonary hypertension.

McLaughlin VV, Gaine SP, Howard LS, Leuchte HH, Mathier MA, Mehta S, Palazzini M, Park MH, Tapson VF, Sitbon O.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D73-81. doi: 10.1016/j.jacc.2013.10.034. Review.

5.

Detection of high-sensitivity troponin in outpatients with stable pulmonary hypertension identifies a subgroup at higher risk of adverse outcomes.

Roy AK, McCullagh BN, Segurado R, McGorrian C, Keane E, Keaney J, Fitzgibbon MN, Mahon NG, Murray PT, Gaine SP.

J Card Fail. 2014 Jan;20(1):31-7. doi: 10.1016/j.cardfail.2013.12.001. Epub 2013 Dec 12.

PMID:
24333348
6.

Case 1: chronic thromboembolic pulmonary hypertension (CTEPH).

Murphy DT, Murphy DM, Murray JG, Gaine SP.

Ir Med J. 2013 May;106(5):146-7. No abstract available.

PMID:
23914576
7.

Case 2: Silicosis.

Murphy DT, Murphy DM, Murray JG, Gaine SP.

Ir Med J. 2013 Jun;106(6):181-2. No abstract available.

PMID:
23909156
8.

Percutaneous atrial septostomy with modified butterfly stent and intracardiac echocardiographic guidance in a patient with syncope and refractory pulmonary arterial hypertension.

Roy AK, Gaine SP, Walsh KP.

Heart Lung Circ. 2013 Aug;22(8):668-71. doi: 10.1016/j.hlc.2013.01.005. Epub 2013 Feb 9.

PMID:
23402682
9.

Management of pulmonary arterial hypertension.

Judge EP, Gaine SP.

Curr Opin Crit Care. 2013 Feb;19(1):44-50. doi: 10.1097/MCC.0b013e32835c5137. Review.

PMID:
23242212
10.

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.

Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, Held M, Grohé C, Lange TJ, Behr J, Klose H, Wilkens H, Filusch A, Germann M, Ewert R, Seyfarth HJ, Olsson KM, Opitz CF, Gaine SP, Vizza CD, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Pittrow D.

Int J Cardiol. 2013 Sep 30;168(2):871-80. doi: 10.1016/j.ijcard.2012.10.026. Epub 2012 Nov 17.

PMID:
23164592
11.

Pulmonary arterial hypertension and the state of limbo.

Gaine SP, Humbert M.

Eur Respir Rev. 2010 Dec;19(118):264-5. doi: 10.1183/09059180.00009510. No abstract available.

12.

Relief of chronic neuropathic pain through endothelin antagonism.

Murphy DM, O'Callaghan DS, Gaine SP.

Am J Med. 2010 Mar;123(3):e7. doi: 10.1016/j.amjmed.2009.07.025. No abstract available.

PMID:
20193818
13.

Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension.

Lavelle A, Sugrue R, Lawler G, Mulligan N, Kelleher B, Murphy DM, Gaine SP.

Eur Respir J. 2009 Sep;34(3):770-1. doi: 10.1183/09031936.00058409. No abstract available.

14.

Medical treatment of pulmonary arterial hypertension.

Adamali H, Gaine SP, Rubin LJ.

Semin Respir Crit Care Med. 2009 Aug;30(4):484-92. doi: 10.1055/s-0029-1233317. Epub 2009 Jul 24. Review.

PMID:
19634087
15.

End points and clinical trial design in pulmonary arterial hypertension.

McLaughlin VV, Badesch DB, Delcroix M, Fleming TR, Gaine SP, Galiè N, Gibbs JS, Kim NH, Oudiz RJ, Peacock A, Provencher S, Sitbon O, Tapson VF, Seeger W.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S97-107. doi: 10.1016/j.jacc.2009.04.007. Review.

16.

Updated clinical classification of pulmonary hypertension.

Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-54. doi: 10.1016/j.jacc.2009.04.012. Review.

17.

Poor outcomes associated with drainage of pericardial effusions in patients with pulmonary arterial hypertension.

Hemnes AR, Gaine SP, Wiener CM.

South Med J. 2008 May;101(5):490-4. doi: 10.1097/SMJ.0b013e31816c0169.

PMID:
18414173
18.

Combination therapy and new types of agents for pulmonary arterial hypertension.

O'Callaghan DS, Gaine SP.

Clin Chest Med. 2007 Mar;28(1):169-85, ix. Review. Erratum in: Clin Chest Med. 2007 Jun;28(2):xi. O'Callaghan, Dermot [corrected to O'Callaghan, Dermot S].

PMID:
17338934
19.

Migraine with aura following atrial septostomy for pulmonary arterial hypertension.

Rogan MP, Walsh KP, Gaine SP.

Nat Clin Pract Cardiovasc Med. 2007 Jan;4(1):55-8.

PMID:
17180151
20.

Sitaxsentan: an endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension.

O'Callaghan DS, Gaine SP.

Int J Clin Pract. 2006 Apr;60(4):475-81.

PMID:
16620363
21.

Lung transplantation for pulmonary hypertension.

Gaine SP, Orens JB.

Semin Respir Crit Care Med. 2001 Oct;22(5):533-40.

PMID:
16088699
22.

Bosentan: a novel agent for the treatment of pulmonary arterial hypertension.

O'Callaghan D, Gaine SP.

Int J Clin Pract. 2004 Jan;58(1):69-73. Review.

PMID:
14994973
23.

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.

McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S; Treprostinil Study Group.

J Cardiovasc Pharmacol. 2003 Feb;41(2):293-9.

PMID:
12548091
24.

Cardiac tamponade in an orthotopic liver recipient with pulmonary hypertension.

Akinci SB, Gaine SP, Post W, Merrit WT, Tan HP, Winters B.

Crit Care Med. 2002 Mar;30(3):699-701.

PMID:
11990938
25.

Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension.

Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW.

Chest. 2001 Nov;120(5):1639-44.

PMID:
11713147
26.

Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries.

Greidinger EL, Gaine SP, Wise RA, Boling C, Housten-Harris T, Wigley FM.

Chest. 2001 Sep;120(3):796-800.

PMID:
11555512
27.

Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol.

Tan HP, Markowitz JS, Montgomery RA, Merritt WT, Klein AS, Thuluvath PJ, Poordad FF, Maley WR, Winters B, Akinci SB, Gaine SP.

Liver Transpl. 2001 Aug;7(8):745-9. Review.

28.

Lung transplantation and systemic sclerosis.

Rosas V, Conte JV, Yang SC, Gaine SP, Borja M, Wigley FM, White B, Orens JB.

Ann Transplant. 2000;5(3):38-43. Review.

PMID:
11147028
29.

Recreational use of aminorex and pulmonary hypertension.

Gaine SP, Rubin LJ, Kmetzo JJ, Palevsky HI, Traill TA.

Chest. 2000 Nov;118(5):1496-7.

PMID:
11083709
30.

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE.

Chest. 2000 Jan;117(1):14-8.

PMID:
10631192
31.

Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease.

Bakst AE, Gaine SP, Rubin LJ.

Chest. 1999 Oct;116(4):1127-9.

PMID:
10531185
32.

Anastomotic pulmonary hypertension after lung transplantation for primary pulmonary hypertension: report of surgical correction.

Soriano CM, Gaine SP, Conte JV, Fairman RP, White C, Rubin LJ.

Chest. 1999 Aug;116(2):564-6.

PMID:
10453890
33.

Induction of heme oxygenase-1 with hemoglobin depresses vasoreactivity in rat aorta.

Gaine SP, Booth G, Otterbein L, Flavahan NA, Choi AM, Wiener CM.

J Vasc Res. 1999 Mar-Apr;36(2):114-9.

PMID:
10213906
34.

Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension.

Yuan JX, Aldinger AM, Juhaszova M, Wang J, Conte JV Jr, Gaine SP, Orens JB, Rubin LJ.

Circulation. 1998 Oct 6;98(14):1400-6.

PMID:
9760294
35.

Short-term outcome and predictors of adverse events following pulmonary thromboendarterectomy.

Gilbert TB, Gaine SP, Rubin LJ, Sequeira AJ.

World J Surg. 1998 Oct;22(10):1029-32; discussion 1033.

PMID:
9747161
36.

Primary pulmonary hypertension.

Gaine SP, Rubin LJ.

Lancet. 1998 Aug 29;352(9129):719-25. Review. Erratum in: Lancet 1999 Jan 2;353(9146):74.

PMID:
9729004
37.

The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.

Conte JV, Gaine SP, Orens JB, Harris T, Rubin LJ.

J Heart Lung Transplant. 1998 Jul;17(7):679-85.

PMID:
9703232
38.

Alpha1L-adrenoceptors in canine pulmonary artery.

Flavahan NA, Hales MA, Aleskowitch TD, Gaine SP, Vanhoutte PM.

J Cardiovasc Pharmacol. 1998 Aug;32(2):308-16.

PMID:
9700995
39.

Action of fenfluramine on voltage-gated K+ channels in human pulmonary-artery smooth-muscle cells.

Wang J, Juhaszova M, Conte JV Jr, Gaine SP, Rubin LJ, Yuan JX.

Lancet. 1998 Jul 25;352(9124):290. No abstract available.

PMID:
9690417
40.

Hypoxic pulmonary endothelial cells release a diffusible contractile factor distinct from endothelin.

Gaine SP, Hales MA, Flavahan NA.

Am J Physiol. 1998 Apr;274(4):L657-64. doi: 10.1152/ajplung.1998.274.4.L657.

PMID:
9575884
41.

Medical and surgical treatment options for pulmonary hypertension.

Gaine SP, Rubin LJ.

Am J Med Sci. 1998 Mar;315(3):179-84. Review.

PMID:
9519930
42.

Attenuated K+ channel gene transcription in primary pulmonary hypertension.

Yuan XJ, Wang J, Juhaszova M, Gaine SP, Rubin LJ.

Lancet. 1998 Mar 7;351(9104):726-7. No abstract available.

PMID:
9504523
43.

Pulmonary alveolar proteinosis: lung transplant or bone marrow transplant?

Gaine SP, O'Marcaigh AS.

Chest. 1998 Feb;113(2):563-4. No abstract available.

PMID:
9498994
44.

Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation.

Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA, Snyder SH.

Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):795-8.

45.

Public attitudes to kidney donation.

Higgins JR, Gaine SP, Chan K, Lam J.

Ir Med J. 1987 Nov;80(11):330. No abstract available.

PMID:
3325454

Supplemental Content

Loading ...
Support Center